June 2011

Mannitol-guided delivery of ciprofloxacin in artificial cystic fibrosis mucus model
Yang Y, Tsifansky MD, Shin S, Lin Q, Yeo Y.

For a complete reference, please click here.

April 2011

Challenges and advances in the development of inhalable drug formulations for cystic fibrosis lung disease
Ibrahim BM, Tsifansky MD, Yang Y, Yeo Y.

For a complete reference, please click here.

January 2010

The Role of Organic Osmolytes in the Response of Cultured Astrocytes to Hyperosmolarity.
Hijab S, Havalad S, Snyder AK

For a complete reference, please click here.

October 2009

Inhalable antibiotic delivery using a dry powder co-delivering recombinant deoxyribonuclease and ciprofloxacin for treatment of cystic fibrosis.
Yang Y, Tsifansky MD, Wu CJ, Yang HI, Schmidt G, Yeo Y.

For a complete reference, please click here.

January 2009

Development of highly porous large PLGA microparticles for pulmonary drug delivery
Yang Y, Bajaj N, Xu P, Ohn K, Tsifansky M, Yeo Y
For a complete reference, please click here.

May 2008

Microparticles for inhalation delivery of antipseudomonal antibodies.
Tsifansky, MD, Yeo, Y, Evgenov, OV, Bellas, E, Benjamin, J
For a complete reference, please click here.

February 2008

Clinical practice guidelines for support of the family in the patient-centered intensive care unit: American College of Critical Care Medicine Task Force 2004-2005.
Davidson JE, Powers K, Hedayat KM, Tieszen M, Kon AA, Shepard E, Spuhler V, Todres ID, Levy M, Barr J, Ghandi R, Hirsch G, Armstrong D

For a complete reference, please click here.